1. Virus-inspired surface-nanoengineered antimicrobial liposome: A potential system to simultaneously achieve high activity and selectivity
- Author
-
Qian Xu, Jing Wang, Xin Pan, Daojun Liu, Biyuan Wu, Jiaying Chi, Chuanbin Wu, Guilan Quan, Feiyuan Yu, Guilin Zhou, Xiaoqian Feng, Jianfeng Cai, Chao Lu, Liming Lin, and Yin Shi
- Subjects
QH301-705.5 ,0206 medical engineering ,Biomedical Engineering ,02 engineering and technology ,Article ,Biomaterials ,Cell membrane ,chemistry.chemical_compound ,Viral envelope ,Plasma membrane fusion ,medicine ,Antimicrobial lipopeptides ,Biology (General) ,Materials of engineering and construction. Mechanics of materials ,Liposome ,biology ,Virus-inspired mimics ,Membrane structure ,Lipopeptide ,Virus-like infections ,021001 nanoscience & nanotechnology ,biology.organism_classification ,Antimicrobial ,020601 biomedical engineering ,medicine.anatomical_structure ,chemistry ,Activity and selectivity ,Liposomes ,Biophysics ,TA401-492 ,0210 nano-technology ,Bacteria ,Biotechnology - Abstract
Enveloped viruses such as SARS-CoV-2 frequently have a highly infectious nature and are considered effective natural delivery systems exhibiting high efficiency and specificity. Since simultaneously enhancing the activity and selectivity of lipopeptides is a seemingly unsolvable problem for conventional chemistry and pharmaceutical approaches, we present a biomimetic strategy to construct lipopeptide-based mimics of viral architectures and infections to enhance their antimicrobial efficacy while avoiding side effects. Herein, a surface-nanoengineered antimicrobial liposome (SNAL) is developed with the morphological features of enveloped viruses, including a moderate size range, lipid-based membrane structure, and highly lipopeptide-enriched bilayer surface. The SNAL possesses virus-like infection to bacterial cells, which can mediate high-efficiency and high-selectivity bacteria binding, rapidly attack and invade bacteria via plasma membrane fusion pathway, and induce a local “burst” release of lipopeptide to produce irreversible damage of cell membrane. Remarkably, viral mimics are effective against multiple pathogens with low minimum inhibitory concentrations (1.6–6.3 μg mL−1), high bactericidal efficiency of >99% within 2 h, >10-fold enhanced selectivity over free lipopeptide, 99.8% reduction in skin MRSA load after a single treatment, and negligible toxicity. This bioinspired design has significant potential to enhance the therapeutic efficacy of lipopeptides and may create new opportunities for designing next-generation antimicrobials., Graphical abstract Image 1
- Published
- 2021